Based on the medical protection-profile, the CNS-penetrable means, as well as the HSP-inducing system of action, arimoclomol may perhaps present a primary-in-course therapy paradigm for GD patients �?significantly clients with currently untreated neurological signs. We therefore investigated the result of arimoclomol on the stability, localization and enzymatic activity of GCase https://robertf196wbf9.tnpwiki.com/user